Effectiveness of Adding Subcutaneous Long-acting Glargine to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
- Status
- COMPLETED
- Phase
- PHASE3
Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1
- Status
- COMPLETED
- Phase
- PHASE1
Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)
- Status
- COMPLETED
- Phase
- PHASE3
Initiation and Titration of Amaryl
- Status
- COMPLETED
- Phase
- PHASE4
Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4
Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials
- Status
- COMPLETED
- Phase
- N/A
Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers
- Status
- TERMINATED
- Phase
- PHASE4
Study on Nutrition and Cardiovascular Risk in Spain.
- Status
- COMPLETED
- Phase
- N/A
Canadian Outpatient VTE Management Registry
- Status
- COMPLETED
- Phase
- N/A
An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2